A new research paper titled "LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair" has been ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Please replace the photo for release dated May 11, 2017 with the accompanying corrected photo. The release reads: LP NOW WARRANTS ITS ENGINEERED WOOD SIDING FOR HAIL ...
A new research paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma ...
Okay. Thank you, everyone, for joining us today for our LP-184 clinical trial results webinar. We'll be talking in depth today with some of our Lantern's team and also with our collaborator and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results